Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00857025 · ClinicalTrials.gov registry record · Phase 1
Beta-Glucan in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase 1 study, sponsored by City of Hope Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT00857025 is a Phase 1 study that has completed, run by City of Hope Medical Center. The registered enrollment target is 20 participants.
The verdict
NCT00857025, a Phase 1 study, has completed, sponsored by City of Hope Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
RATIONALE: Biological therapies, such as beta-glucan, may stimulate the immune system in different ways and stop tumor cells from growing. PURPOSE: This phase I trial is studying the side effects and best dose of beta-glucan in treating patients with locally advanced or metastatic non-small cell lung cancer.
Interventions
- OTHER laboratory biomarker analysis
- OTHER questionnaire administration
- OTHER flow cytometry
- BIOLOGICAL beta-glucan MM-10-001
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2008-11-21 |
| Est. Completion | 2021-05-18 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00857025
The ClinicalTrials.gov registry entry for NCT00857025 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which laboratory biomarker analysis is the first listed.
NCT00857025 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00857025 about?
NCT00857025 is a clinical study titled "Beta-Glucan in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer". RATIONALE: Biological therapies, such as beta-glucan, may stimulate the immune system in different ways and stop tumor cells from growing. PURPOSE: This phase I trial is studying the side effects and best dose of beta-glucan in treating patients with locally advanced or metastatic non-small cell lu...
What is the current status of trial NCT00857025?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2008-11-21. Estimated completion is 2021-05-18.
What interventions are being tested in trial NCT00857025?
The interventions under investigation include: laboratory biomarker analysis (OTHER), questionnaire administration (OTHER), flow cytometry (OTHER), beta-glucan MM-10-001 (BIOLOGICAL).
Who is sponsoring clinical trial NCT00857025?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.